Pharma & Life Sciences Gain an Efficiency Upgrade Through Robotics
Gabrielle Bejarano from Benchmark Products discusses how robotics and automation technologies are transforming the pharmaceutical and life sciences industries. The integration of these technologies enhances operational efficiency and safety during critical disruptions such as the COVID-19 pandemic. Robotics ensure continuity in drug development and manufacturing by reducing manual tasks.
This story was produced through MarketScale. See how Engineering & Construction teams put it to work with Partner & Channel Enablement.
Promoted content from Benchmark Products on MarketScale.
Key takeaways
Robotics and automation improve operational efficiency in pharmaceuticals.
These technologies maintain productivity during disruptions like COVID-19.
Reduced manual tasks in drug development enhance safety and innovation.
How is the integration of robotics transforming the pharmaceutical and life sciences industries into more efficient, safe, and innovative fields?
Gabrielle Bejarano, representing Benchmark Products, sheds light on the significant impact of robotics and automation technologies, emphasizing their role in enhancing operational efficiency and safety across drug development and manufacturing processes. "The COVID-19 pandemic accelerated this trend with robotics ensuring operational continuity amidst lockdown restrictions," Bejarano revealed, highlighting the critical role of robotics in maintaining industry operations during unprecedented times.
The COVID-19 pandemic accelerated this trend with robotics ensuring operational continuity amidst lockdown restrictions.
— Gabrielle Bejarano, Benchmark Products
Part of this channel
Benchmark Products
ISO-certified cleanroom supplies for life science manufacturers.
About the author
